Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1450134 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Sialic Acid Binding Ig-Like Lectin 15 (SIGLEC15) (N-Term) antibody
- Antibody type
- Polyclonal
- Antigen
- 15 amino acid synthetic peptide near the amino terminus of Human SIGLEC15
- Description
- Affinity chromatography purified via peptide column
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- N-Term
- Isotype
- IgG
- Vial size
- 0.1 mg
- Concentration
- 1.0 mg/mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Siglec-15, a member of the sialic acid-binding lectin, is a novel regulator for osteoclast differentiation.
Siglecs as positive and negative regulators of the immune system.
Siglec-15: an immune system Siglec conserved throughout vertebrate evolution.
[Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
Hiruma Y, Hirai T, Tsuda E
Biochemical and biophysical research communications 2011 Jun 10;409(3):424-9
Biochemical and biophysical research communications 2011 Jun 10;409(3):424-9
Siglecs as positive and negative regulators of the immune system.
Crocker PR, Redelinghuys P
Biochemical Society transactions 2008 Dec;36(Pt 6):1467-71
Biochemical Society transactions 2008 Dec;36(Pt 6):1467-71
Siglec-15: an immune system Siglec conserved throughout vertebrate evolution.
Angata T, Tabuchi Y, Nakamura K, Nakamura M
Glycobiology 2007 Aug;17(8):838-46
Glycobiology 2007 Aug;17(8):838-46
[Therapy of hepatocellular carcinoma with UFT--clinical evaluation of its effect in the combination therapy with transcatheter arterial embolization or one shot therapy].
Kitamura T, Maruyama T, Nakamura H, Hayashi K, Shigehira M, Iwaki Y, Okamoto T, Ishikawa T, Ishinoda Y, Kisanuki H
Gan to kagaku ryoho. Cancer & chemotherapy 1990 Aug;17(8 Pt 1):1467-71
Gan to kagaku ryoho. Cancer & chemotherapy 1990 Aug;17(8 Pt 1):1467-71
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of SIGLEC15 in Rat kidney tissue lysate with SIGLEC15 antibody at (A) 1 and (B) 2 ug/mL
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Immunohistochemistry of SIGLEC15 in human kidney tissue with SIGLEC15 antibody at 2.5 ug/mL.
